Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Analysis of the host transcriptome from demyelinating spinal cord of murine coronavirus-infected mice.
Comparison of IFN-β inducible gene expression in primary-progressive and relapsing-remitting multiple sclerosis.
Association Between Self-Administered Expanded Disease Severity Scale (Edss) and Multiple Sclerosis Impact Scale (Msis-29): Results from The Burden of Illness In Patients With Multiple Sclerosis In Finland (Defense) Study.
Peripheral blood non-MAIT CD8+CD161hi cells are decreased in relapsing-remitting multiple sclerosis patients treated with interferon beta.
Editorial: Fatigue in Multiple Sclerosis.
Cerebrospinal fluid lipocalin 2 in patients with clinically isolated syndromes and early multiple sclerosis.
TGF-beta1 regulates human brain pericyte inflammatory processes involved in neurovasculature function.
Is Modulation of Oxidative Stress an Answer? The State of the Art of Redox Therapeutic Actions in Neurodegenerative Diseases.
Brachial plexus atrophy in chronic inflammatory demyelinating polyradiculoneuropathy.
Molecular basis of axonal dysfunction and traffic impairments in CMT.
Metabolic response to epigallocatechin-3-gallate in relapsing-remitting multiple sclerosis: a randomized clinical trial.
Novel Insights and Therapeutics in Multiple Sclerosis.
Diffusion kurtosis imaging probes cortical alterations and white matter pathology following cuprizone induced demyelination and spontaneous remyelination.
Brain intra- and extracellular sodium concentration in multiple sclerosis: a 7 T MRI study.
Does Physical Activity Change Over 24 Months in Persons With Relapsing-Remitting Multiple Sclerosis?
Is a hypothetical melanoma-like neuromelanin the underlying factor essential for the aetiopathogenesis and clinical manifestations of multiple sclerosis?
Demyelinating disease and psoriasis: Interferon versus dimethyl fumarate.
Extracellular Vesicles and a Novel Form of Communication in the Brain.
Low quality of life and psychological wellbeing contrast with moderate perceived burden in carers of people with severe multiple sclerosis.
Diagnostic value of visual evoked potentials for clinical diagnosis of multiple sclerosis.
Pharmacological Approaches to Delaying Disability Progression in Patients with Multiple Sclerosis.
LINGO-1 antibody ameliorates myelin impairment and spatial memory deficits in experimental autoimmune encephalomyelitis mice.
Homeostasis of Microglia in the Adult Brain: Review of Novel Microglia Depletion Systems.
Steroids for chronic inflammatory demyelinating polyradiculoneuropathy: evidence base and clinical practice.
Exploration of changes in disability after menopause in a longitudinal multiple sclerosis cohort.
Pages
« first
‹ previous
…
696
697
698
699
700
701
702
703
704
…
next ›
last »